New Delhi, Apr 30 (PTI) Gland Pharma on Wednesday said it has received approval from the US health regulator for a generic medication to treat conditions related to high pressure in the eye. The ...

When Covid-19 emerged, it became clear that conventional approaches to health care and drug development wouldn’t suffice. What followed was nothing short of transformational. In under 12 months ...

"His deep expertise in oncology drug discovery and development, and his leadership of world-class R&D organizations, are a great match for our platform and pipeline rooted in innovative science ...

Morepen Laboratories has received approval from India’s Central Drugs Standard Control Organization (CDSCO) to conduct bioequivalence studies for Resmetirom tablets, a potential treatment for ...

The inexpensive diabetes pill metformin significantly reduced pain from knee osteoarthritis in a small trial of people who are overweight or have obesity. Results from a small trial suggest that ...

The latest advances in drug development, particularly with glucagon-like peptide-1 (GLP-1) receptor agonists, are revolutionising the treatment landscape. However, this progress doesn’t come without ...

Pakistan’s pharma sector is increasingly deploying artificial intelligence (AI) and advanced technologies to improve drug development processes and detect drug reactions, it was learnt.

The company is strategically targeting markets where patents expire earliest, with India's launch timeline slightly later than Canada and Brazil, he indicated at the Nasscom GCC Summit here.

As the ALS field progresses, 200+ scientific leaders will gather in Boston at the 4th ALS Drug Development Summit to address the most pressing challenges in therapy development. Discussions will ...

The rate is slightly higher for branded drugs, where 15% of API manufacturing takes place in the U.S., while the rate for generic ingredients is on par with the overall 12% figure, according to ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro ...